Merrimack Pharmaceuticals

www.merrimackpharma.com

Investment Type: IPO

Date of IPO: 05/2012

Merrimack Pharmaceuticals is an integrated, biopharmaceutical company committed to the innovation of life-enhancing medicines for the treatment of autoimmune disease and cancer. Merrimack is privately held and located in Cambridge, Massachusetts.